CATLIN REGENERATION LTD

Company number 13724279 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

CATLIN REGENERATION LTD - Analysis Report

Company Number: 13724279

Analysis Date: 2025-07-20 17:16 UTC

Financial Health Assessment for CATLIN REGENERATION LTD (as at 30 November 2023)


1. Financial Health Score: D

Explanation:
The company exhibits significant financial distress indicated by substantial net current liabilities and negative shareholders' funds, creating a "symptom" of poor liquidity and solvency. The negative net assets and worsening position over two years suggest underlying financial strain needing urgent attention.


2. Key Vital Signs

Metric 2023 Value (£) 2022 Value (£) Interpretation
Current Assets 23,146 7,716 Slight improvement in liquid resources
Current Liabilities 220,705 49,241 Sharp increase in short-term debts (red flag)
Net Current Assets -197,559 -41,525 Deepening working capital deficit (critical)
Net Assets (Shareholders’ Funds) -197,559 -42,025 Increasing negative equity, indicating insolvency risk
Average Number of Employees 1 1 Small, micro-entity scale
  • Liquidity ("Cash Flow Pulse"): Negative net current assets indicate the company does not have enough liquid resources to cover immediate debts, a serious symptom of cash flow distress.
  • Solvency ("Balance Sheet Vitality"): Net liabilities have grown significantly, reflecting that the company owes more than it owns, which can threaten long-term survival.
  • Operational Scale: Micro-entity status with a single employee, limiting operational capacity and financial leverage.

3. Diagnosis

The financial "symptoms" reveal a company in distress:

  • The drastic increase in current liabilities (+348% approx.) over one year, with only modest increases in current assets, indicates reliance on short-term financing or accruing debts that outpace resources.
  • Negative net assets suggest the company’s liabilities exceed its assets, signaling potential insolvency if this trend persists.
  • The consistent negative equity over the past two years with worsening figures suggests accumulated losses or inability to generate sufficient profits or capital injections.
  • The company operates in real estate investment trusts activities, a sector that often requires significant capital and stable financing. The financial data suggests the company may be struggling to fund its investment activities or meet creditor demands.
  • The director has certified exemption from audit, typical for micro companies, but this limits insight into operational profitability and cash flow beyond balance sheet data.

In medical analogy, the company shows "symptoms of systemic financial distress" with "poor liquidity" and "weak solvency," akin to a patient with a failing circulatory system—urgent intervention is needed to restore health.


4. Recommendations

To improve financial wellness and prevent progression towards insolvency, the company should consider:

  • Liquidity Management:
    • Negotiate extended payment terms with creditors to ease short-term cash outflows.
    • Accelerate collection of any receivables or convert assets into cash promptly.
    • Explore short-term financing options with favourable terms to cover immediate liabilities.
  • Capital Injection:
    • Consider raising equity capital from existing shareholders or new investors to shore up negative net assets.
    • Evaluate potential for shareholder loans or director advances to provide a financial "transfusion."
  • Cost Control and Operational Review:
    • Assess operational costs and reduce non-essential expenses to conserve cash.
    • Review the business model to ensure revenue streams are sustainable and sufficient to cover liabilities.
  • Strategic Financial Planning:
    • Develop a robust cash flow forecast to anticipate liquidity needs and plan accordingly.
    • Engage financial advisors to explore restructuring options if debt levels remain unmanageable.
  • Governance and Transparency:
    • Although audit exemption is in place, consider voluntary external review to reassure stakeholders and identify financial risks.
    • Maintain timely and accurate filings to preserve credibility and avoid penalties.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.